98 related articles for article (PubMed ID: 31155487)
1. Lipid Fraction Derived From MRI In- and Opposed-Phase Sequence as a Novel Biomarker for Predicting Survival Outcome of Glioma.
Seow P; Narayanan V; Romelean RJ; Wong JHD; Win MT; Chandran H; Chinna K; Rahmat K; Ramli N
Acad Radiol; 2020 Feb; 27(2):180-187. PubMed ID: 31155487
[TBL] [Abstract][Full Text] [Related]
2. Novel application of chemical shift gradient echo in- and opposed-phase sequences in 3 T MRI for the detection of H-MRS visible lipids and grading of glioma.
Ramli N; Khairy AM; Seow P; Tan LK; Wong JH; Ganesan D; Rahmat K
Eur Radiol; 2016 Jul; 26(7):2019-29. PubMed ID: 26560718
[TBL] [Abstract][Full Text] [Related]
3. Quantification and visualization of lipid landscape in glioma using in -and opposed-phase imaging.
Seow P; Narayanan V; Hernowo AT; Wong JHD; Ramli N
Neuroimage Clin; 2018; 20():531-536. PubMed ID: 30167373
[TBL] [Abstract][Full Text] [Related]
4.
Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
[TBL] [Abstract][Full Text] [Related]
6. IVIM perfusion fraction is prognostic for survival in brain glioma.
Federau C; Cerny M; Roux M; Mosimann PJ; Maeder P; Meuli R; Wintermark M
Clin Neuroradiol; 2017 Dec; 27(4):485-492. PubMed ID: 27116215
[TBL] [Abstract][Full Text] [Related]
7. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
[TBL] [Abstract][Full Text] [Related]
8. Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis of the patients with high-grade gliomas.
Wang X; Gao W; Li F; Shi W; Li H; Zeng Q
Magn Reson Imaging; 2019 Nov; 63():131-136. PubMed ID: 31425809
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
10. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of human glioma using in-vivo proton magnetic resonance spectroscopy combined with expression of cyclooxygenase-2: a preliminary clinical trial.
Shi W; Li F; Li H; Xu Y; Zeng Q
Neuroreport; 2017 May; 28(7):414-420. PubMed ID: 28306608
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
13. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
[TBL] [Abstract][Full Text] [Related]
14. The roles of
Kim S; Kim D; Kim SH; Park MA; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1012-1020. PubMed ID: 29511838
[TBL] [Abstract][Full Text] [Related]
15. Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.
Chen BB; Lu YS; Yu CW; Lin CH; Chen TW; Wei SY; Cheng AL; Shih TT
Eur Radiol; 2018 Nov; 28(11):4860-4870. PubMed ID: 29770848
[TBL] [Abstract][Full Text] [Related]
16. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
17. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
18. Imaging biomarker analysis of advanced multiparametric MRI for glioma grading.
Vamvakas A; Williams SC; Theodorou K; Kapsalaki E; Fountas K; Kappas C; Vassiou K; Tsougos I
Phys Med; 2019 Apr; 60():188-198. PubMed ID: 30910431
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
20. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
